Federal judge sentences Purdue Pharma to $5.5 billion in criminal penalties
A federal judge sentenced OxyContin manufacturer Purdue Pharma to $5.5 billion in criminal penalties on Tuesday, marking the final step before the company's dissolution. The sentence resolves the Department of Justice's criminal fraud case against Purdue, which pleaded guilty in 2020 to deceiving regulators and paying kickbacks. The company will be replaced by Knoa Pharma, focused on addressing the opioid crisis.
8
Divergence score
2 outlets covered it, splitting into 2 framing camps across 2 bias groups.
2 camps
2 bias groups
The spectrum · how 2 outlets placed this story
LeftCenterRight
Washington Examiner
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
The Washington Examiner emphasizes Purdue's replacement by Knoa Pharma and frames it as addressing the opioid crisis, while Reuters focuses on the sentence enabling settlement for individual lawsuits.
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 2 outlets
“Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement”
“OxyContin maker Purdue Pharma set to dissolve after judge approves sentence”
Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed